However, given the compelling evidence of a strong correlation between elevated levels of HIF-1 and tumor metastasis, angiogenesis, poor patient prognosis, and tumor resistance, concerns regarding the potential off-target effects of HIF-PHD inhibitors have been raised (Tan et al., 2025). The gene discussed is HIF1A; the disease is neoplasm.